SCHEMBL2079715

SCHEMBL2079715

O=[N+]([O-])c1ccc(Cl)cc1/C(Cl)=N\O

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ ALDH1A1 P00352 3/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ KMT2A Q03164 2/20 0.45
▸ GAA P10253 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ POLB P06746 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ VCAM1 P19320 1/20 0.42
▸ MAPT P10636 2/20 0.41
▸ PLA2G1B P04054 1/20 0.41
▸ ATG4B Q9Y4P1 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ KCNMA1 Q12791 1/20 0.41
▸ P2RX1 P51575 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2079716 1.00 TSHR (0.53) TSHRMAPK1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL14375069 1.00 TSHR (0.53) TSHRMAPK1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL40329 0.81 ALDH1A1 (0.59) TSHRMAPK1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL79163 0.77 DTYMK (0.62) TSHRMAPK1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL16956717 0.77 TSHR (0.58) TSHRMAPK1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL6156834 0.77 ALDH1A1 (0.53) ALDH1A1KMT2AMEN1MAPTTDP1
SCHEMBL6156831 0.77 ALDH1A1 (0.53) ALDH1A1KMT2AMEN1MAPTTDP1
SCHEMBL339922 0.76 ALDH1A1 (0.57) TSHRMAPK1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL6395556 0.76 ALDH1A1 (0.57) TSHRMAPK1ALDH1A1SMN1; SMN2KMT2A
Hydrochloric Acid SCHEMBL1138798 0.76 DTYMK (0.60) TSHRMAPK1ALDH1A1SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7906538-B2 Parasiticides; nematocides; crop protection SCHERING-PLOUGH ANIMAL HEALTH CORPORATION (US) 2011-03-15 — — US disclosed
US-20080262048-A1 CONTROL OF PARASITES IN ANIMALS BY THE USE OF NOVEL TRIFLUOROMETHANESULFONANILIDE OXIME ETHER DERIVATIVES SCHERING-PLOUGH ANIMAL HEALTH CORPORATION 2008-10-23 — — US disclosed
EP-1799636-B1 CONTROL OF PARASITES IN ANIMALS BY THE USE OF NOVEL TRIFLUOROMETHANESULFONANILIDE OXIME ETHER DERIVATIVES SCHERING PLOUGH LTD (CH) 2008-08-27 — — EP disclosed
US-7312248-B2 Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives SCHERING-PLOUGH ANIMAL HEALTH CORPORATION (US) 2007-12-25 — — US disclosed
EP-1799636-A2 CONTROL OF PARASITES IN ANIMALS BY THE USE OF NOVEL TRIFLUOROMETHANESULFONANILIDE OXIME ETHER DERIVATIVES Schering-Plough Ltd. (CH) 2007-06-27 — — EP disclosed
WO-2006034333-A2 CONTROL OF PARASITES IN ANIMALS BY THE USE OF NOVEL TRIFLUOROMETHANESULFONANILIDE OXIME ETHER DERIVATIVES SCHERING-PLOUGH LTD. (CH) 2006-03-30 — — WO disclosed
US-20060063841-A1 Parasiticides; nematocides; crop protection SCHERING-PLOUGH LTD. (CH) 2006-03-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063841-A1 Parasiticides; nematocides; crop protection TRHDE, DDT, EPHX1 TSHR 1334/4885MAPK1 3689/4885ALDH1A1 4339/4885
US-20080262048-A1 CONTROL OF PARASITES IN ANIMALS BY THE USE OF NOVEL TRIFLUOROMETHANESULFONANILIDE OXIME ETHER DERIVATIVES TRHDE, EPX, EPHX1 TSHR 414/4885MAPK1 3695/4885ALDH1A1 3635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback